Arjan J. Groot

2.5k total citations
38 papers, 1.7k citations indexed

About

Arjan J. Groot is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Arjan J. Groot has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Arjan J. Groot's work include Cancer, Hypoxia, and Metabolism (16 papers), Virus-based gene therapy research (5 papers) and Cancer Cells and Metastasis (5 papers). Arjan J. Groot is often cited by papers focused on Cancer, Hypoxia, and Metabolism (16 papers), Virus-based gene therapy research (5 papers) and Cancer Cells and Metastasis (5 papers). Arjan J. Groot collaborates with scholars based in Netherlands, United States and United Kingdom. Arjan J. Groot's co-authors include Marc Vooijs, P. J. van Diest, Jan Theys, R. Habets, Elsken van der Wall, Eelke Gort, Leo W. J. Klomp, Cisca Wijmenga, Bart van de Sluis and Jarosław Dastych and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Arjan J. Groot

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arjan J. Groot Netherlands 24 985 533 435 227 159 38 1.7k
Shinichiro Nakamura Japan 30 897 0.9× 410 0.8× 447 1.0× 269 1.2× 210 1.3× 122 2.6k
Peter Ping Lin United States 32 802 0.8× 638 1.2× 950 2.2× 608 2.7× 319 2.0× 69 2.5k
Kosuke Akiyama Japan 30 1.5k 1.6× 761 1.4× 685 1.6× 260 1.1× 218 1.4× 115 2.5k
Isabelle Bourget France 24 1.0k 1.0× 500 0.9× 625 1.4× 395 1.7× 147 0.9× 32 1.9k
Simon J. A. Buczacki United Kingdom 16 941 1.0× 339 0.6× 1.0k 2.4× 175 0.8× 142 0.9× 31 1.9k
Nancy Gavert Israel 24 1.3k 1.3× 403 0.8× 809 1.9× 206 0.9× 167 1.1× 39 2.4k
Sophie Javerzat France 19 968 1.0× 263 0.5× 309 0.7× 132 0.6× 89 0.6× 33 1.4k
Anita J. Merritt United Kingdom 18 1.3k 1.3× 266 0.5× 785 1.8× 118 0.5× 148 0.9× 23 2.3k
Jason Howitt Australia 23 1.7k 1.7× 541 1.0× 201 0.5× 208 0.9× 70 0.4× 34 2.2k
Dalit Barkan Israel 18 759 0.8× 444 0.8× 904 2.1× 311 1.4× 161 1.0× 26 1.9k

Countries citing papers authored by Arjan J. Groot

Since Specialization
Citations

This map shows the geographic impact of Arjan J. Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arjan J. Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arjan J. Groot more than expected).

Fields of papers citing papers by Arjan J. Groot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arjan J. Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arjan J. Groot. The network helps show where Arjan J. Groot may publish in the future.

Co-authorship network of co-authors of Arjan J. Groot

This figure shows the co-authorship network connecting the top 25 collaborators of Arjan J. Groot. A scholar is included among the top collaborators of Arjan J. Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arjan J. Groot. Arjan J. Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menegakis, Apostolos, Claire Vennin, Jonathan Ient, et al.. (2024). A novel lineage-tracing tool reveals that hypoxic tumor cells drive tumor relapse after radiotherapy. Radiotherapy and Oncology. 202. 110592–110592.
2.
Vermeer, Jenny A. F., Jonathan Ient, Boštjan Markelc, et al.. (2020). A lineage-tracing tool to map the fate of hypoxic tumour cells. Disease Models & Mechanisms. 13(7). 5 indexed citations
3.
Gong, Ying, Roel G. J. Klein Wolterink, Ian Janssen, et al.. (2020). Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor. Molecular Therapy — Methods & Clinical Development. 17. 634–646. 38 indexed citations
4.
Groot, Arjan J., Ala Yaromina, Lorena Giuranno, et al.. (2019). HIF-1α and HIF-2α Differently Regulate the Radiation Sensitivity of NSCLC Cells. Cells. 8(1). 45–45. 39 indexed citations
5.
Habets, R., Marco B.E. Schaaf, Sanaz Yahyanejad, et al.. (2019). The anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to γ-secretase inhibition. Oncogene. 38(27). 5457–5468. 23 indexed citations
6.
Theys, Jan, Arjan J. Groot, Ala Yaromina, et al.. (2018). Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells. Frontiers in Oncology. 8. 460–460. 24 indexed citations
7.
Yaromina, Ala, et al.. (2018). Prognostic Role of Hypoxia-Inducible Factor-2α Tumor Cell Expression in Cancer Patients: A Meta-Analysis. Frontiers in Oncology. 8. 224–224. 41 indexed citations
8.
Habets, R., Arjan J. Groot, Sanaz Yahyanejad, et al.. (2015). Human NOTCH2 Is Resistant to Ligand-independent Activation by Metalloprotease Adam17. Journal of Biological Chemistry. 290(23). 14705–14716. 21 indexed citations
9.
Xu, Xiang, Sung Hee Choi, Tiancen Hu, et al.. (2015). Insights into Autoregulation of Notch3 from Structural and Functional Studies of Its Negative Regulatory Region. Structure. 23(7). 1227–1235. 49 indexed citations
10.
Theys, Jan, Sanaz Yahyanejad, R. Habets, et al.. (2013). High NOTCH activity induces radiation resistance in non small cell lung cancer. Radiotherapy and Oncology. 108(3). 440–445. 55 indexed citations
11.
Groot, Arjan J. & Marc Vooijs. (2012). The Role of Adams in Notch Signaling. Advances in experimental medicine and biology. 727. 15–36. 84 indexed citations
12.
Sluis, Bart van de, Xicheng Mao, Yali Zhai, et al.. (2010). COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion. Journal of Clinical Investigation. 120(6). 2119–2130. 103 indexed citations
13.
Müller, Patricia, Bart van de Sluis, Arjan J. Groot, et al.. (2009). Nuclear‐Cytosolic Transport of COMMD1 Regulates NF‐κB and HIF‐1 Activity. Traffic. 10(5). 514–527. 45 indexed citations
14.
Sluis, Bart van de, Arjan J. Groot, Jeroen F. Vermeulen, et al.. (2009). COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1α via HSP90/70. PLoS ONE. 4(10). e7332–e7332. 48 indexed citations
15.
Groot, Arjan J., Mohamed El Khattabi, Norman Sachs, et al.. (2009). Reverse proteomic antibody screening identifies anti adhesive VHH targeting VLA-3. Molecular Immunology. 46(10). 2022–2028. 11 indexed citations
16.
Gort, Eelke, Gijs van Haaften, Ingrid Verlaan, et al.. (2007). The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2α. Oncogene. 27(11). 1501–1510. 110 indexed citations
17.
Sluis, Bart van de, Arjan J. Groot, Cisca Wijmenga, Marc Vooijs, & Leo W. J. Klomp. (2007). COMMD1: A Novel Protein Involved in the Proteolysis of Proteins. Cell Cycle. 6(17). 2091–2098. 15 indexed citations
18.
Verheesen, Peter, Andreas Roussis, Hans J. de Haard, et al.. (2006). Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1764(8). 1307–1319. 55 indexed citations
19.
Bergh, Anne R. M. von, et al.. (2004). Identification of a novel RAS GTPase‐activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia. Genes Chromosomes and Cancer. 39(4). 324–334. 20 indexed citations
20.
Koningsbruggen, Silvana van, Hans de Haard, Peggy de Kievit, et al.. (2003). Llama-derived phage display antibodies in the dissection of the human disease oculopharyngeal muscular dystrophy. Journal of Immunological Methods. 279(1-2). 149–161. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinichiro Nakamura Breakdown of academic impact, for papers by Peter Ping Lin Breakdown of academic impact, for papers by Kosuke Akiyama Breakdown of academic impact, for papers by Isabelle Bourget Breakdown of academic impact, for papers by Simon J. A. Buczacki Breakdown of academic impact, for papers by Nancy Gavert Breakdown of academic impact, for papers by Sophie Javerzat Breakdown of academic impact, for papers by Anita J. Merritt Breakdown of academic impact, for papers by Jason Howitt Breakdown of academic impact, for papers by Dalit Barkan
Rankless by CCL
2026